Features

Viewpoints

On-Body Injections of Pegfilgrastim May Not Always Be Preferred — But They’re On Schedule

By

Julia Faith Sklar

Publish Date November 4, 2020

Preferences are tied not just to the experience of receiving an injection, but also to factors related to a patient’s access to different types of care settings.

American Cancer Society Updates Cervical Cancer Screening Guidelines

By

Victoria Forster, PhD

Publish Date September 16, 2020

New guidelines from the American Cancer Society (ACS) appear to move away from the reliance on cytology screening via Pap testing.

From the Advisory Board

We Can Treat Hodgkin’s Lymphoma Like Melanoma?

By

Isabel Cunningham, MD

Publish Date September 3, 2015

Isabel Cunningham, MD, Cancer Therapy Advisor Advisory Board member, weighs in on recent discoveries in the treatment of hematologic cancers.

Slideshows

BAVENCIO (avelumab) for Merkel Cell Carcinoma

IMLYGIC (talimogene laherparepvec) for Melanoma

Features

KRAS G12C Mutations in Metastatic Colorectal Cancer: Questions Remain

By

Alan P. Lyss, MD

Publish Date July 30, 2021

Dr Alan Lyss reviews studies of KRAS G12C mutations in metastatic colorectal cancer.

Treatment Strategies and Challenges in Chronic Lymphocytic Leukemia

By

Tori Rodriguez, MA, LPC, AHC

Publish Date July 29, 2021

Researchers sought to clarify the current treatment strategies and challenges for patients with chronic lymphocytic leukemia.

Racial/Ethnic Minorities Have Higher Risk of Familial-Associated Early-Onset Cancer

By

Jon Kelvey

Publish Date July 27, 2021

The study showed differences by cancer type and race/ethnicity.